Goldman Sachs’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-550,942
| Closed | -$28.1M | – | 5323 |
|
|
2024
Q4 | $28.1M | Buy |
550,942
+275,005
| +100% | +$14M | ﹤0.01% | 1510 |
|
|
2024
Q3 | $11.4M | Sell |
275,937
-58,688
| -18% | -$2.42M | ﹤0.01% | 2148 |
|
|
2024
Q2 | $16.1M | Buy |
334,625
+93,007
| +38% | +$4.48M | ﹤0.01% | 1728 |
|
|
2024
Q1 | $11.6M | Buy |
241,618
+59,969
| +33% | +$2.88M | ﹤0.01% | 1949 |
|
|
2023
Q4 | $11.8M | Sell |
181,649
-6,296
| -3% | -$409K | ﹤0.01% | 1949 |
|
|
2023
Q3 | $12.3M | Sell |
187,945
-621,824
| -77% | -$40.7M | ﹤0.01% | 1837 |
|
|
2023
Q2 | $47.1M | Buy |
809,769
+330,296
| +69% | +$19.2M | 0.01% | 988 |
|
|
2023
Q1 | $29.6M | Sell |
479,473
-82,313
| -15% | -$5.08M | 0.01% | 1236 |
|
|
2022
Q4 | $35.7M | Buy |
561,786
+119,280
| +27% | +$7.58M | 0.01% | 1191 |
|
|
2022
Q3 | $32.1M | Buy |
442,506
+133,928
| +43% | +$9.73M | 0.01% | 1244 |
|
|
2022
Q2 | $21M | Sell |
308,578
-5,602
| -2% | -$381K | 0.01% | 1580 |
|
|
2022
Q1 | $28.5M | Buy |
314,180
+148,575
| +90% | +$13.5M | 0.01% | 1473 |
|
|
2021
Q4 | $15.1M | Buy |
165,605
+107,593
| +185% | +$9.82M | ﹤0.01% | 1960 |
|
|
2021
Q3 | $4.7M | Sell |
58,012
-2,683
| -4% | -$218K | ﹤0.01% | 2838 |
|
|
2021
Q2 | $5.66M | Buy |
60,695
+32,952
| +119% | +$3.07M | ﹤0.01% | 2692 |
|
|
2021
Q1 | $2.97M | Sell |
27,743
-14,700
| -35% | -$1.57M | ﹤0.01% | 3046 |
|
|
2020
Q4 | $3.71M | Buy |
+42,443
| New | +$3.71M | ﹤0.01% | 2661 |
|
|
2020
Q3 | – | Sell |
-41,805
| Closed | -$2.03M | – | 4589 |
|
|
2020
Q2 | $2.03M | Buy |
+41,805
| New | +$2.03M | ﹤0.01% | 2835 |
|